• Uncommon in large bowel; most occur in the rectum
• Lesions < 2 cm in diameter usually are asymptomatic, behave benignly, and can be managed by local excision
• Larger tumors arising in the colon (mainly the right side) or rectum cause local symptoms, often metastasize, and require standard cancer resection
• Carcinoid syndrome appears in fewer than 5% of patients with metastatic carcinoid of the large bowel
• Derived from cells that are capable of synthesizing a wide variety of hormones
• 60% of rectal carcinoids present as asymptomatic submucosal nodules measuring < 2 cm in diameter
• Rare; account for < 0.5% of all colorectal malignancies
• The documentation of widespread dissemination of lymphoma in most cases underscores the concept that lymphoma of the GI tract is a systemic disease in which tumor cells are present in other organ sites
• Extremely rare: account for < 0.1% of all large bowel malignancies
• Most common histologic subtype is leiomyosarcoma
• Most significant prognostic indicator is tumor grade
• Carcinoids of the colon are uncommon (2% of GI carcinoids) and most of them occur in the rectum (15% of GI carcinoids)
• Lymphomas are the most common noncarcinomatous malignant tumors of the large bowel; primary non-Hodgkin colonic lymphoma account for 10% of GI lymphomas
• Sarcomas represent < 1% of colonic tumors, with peak incidence in sixth decade of life
• History and physical exam
• Colonoscopy with biopsy
• Staging studies: Chest film, abdominal CT scan, liver function tests
• For lymphoma: Bone marrow biopsy
• Because this disease is highly responsive to chemotherapy and radiation, surgery is not always the primary mode of therapy
• Usually, for localized, low-grade colorectal lymphomas, radiation is considered first-line therapy
• Intermediate- and high-grade lymphomas, chemotherapy combined with radiation therapy should be the primary treatment
• Rectal carcinoid: Transanal local excision suffices for definitive therapy because small tumors rarely metastasize
• Lymphoma: Surgery has been primarily for diagnostic and staging purposes and for the management of treatment-related complications (ie, perforation or bleeding).
• Sarcoma: If tumors are clinically localized at initial presentation, a radical en bloc excision should be performed to obtain a margin of ...
Log In to View More
If you don't have a subscription, please view our individual subscription options below to find out how you can gain access to this content.
Want remote access to your institution's subscription?
Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.
If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.
AccessSurgery Full Site: One-Year Subscription
Connect to the full suite of AccessSurgery content and resources including more than 160 instructional videos, 16,000+ high-quality images, interactive board review, 20+ textbooks, and more.
Pay Per View: Timed Access to all of AccessSurgery
24 Hour Subscription $34.95
48 Hour Subscription $54.95
Pop-up div Successfully Displayed
This div only appears when the trigger link is hovered over.
Otherwise it is hidden from view.